Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer McVige

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Continuum (Minneapolis, Minn.)|June 4, 2015
Coding in behavioral neurology and neuropsychiatryJoseph V Fritz, Jennifer McVige, Laszlo Mechtler
Current Pain and Headache Reports|June 27, 2016
Basilar Invagination, Basilar Impression, and Platybasia: Clinical and Imaging AspectsNandor K Pinter, Jennifer McVige, Laszlo Mechtler
Headache|October 26, 2022
A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extensionMarcy E Yonker, Jennifer McVige, Leonid Zeitlin, et al.
Sports Health|March 30, 2016
A Practical Concussion Physical Examination ToolboxJason M Matuszak, Jennifer McVige, Jacob McPherson, et al.
Frontiers in Neurology|January 24, 2022
Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic MigraineLaszlo Mechtler, Nicolas Saikali, Jennifer McVige, et al.
Pain Medicine (Malden, Mass.)|June 29, 2021
Comparison of Remote Electrical Neuromodulation and Standard-Care Medications for Acute Treatment of Migraine in Adolescents: A Post Hoc AnalysisAndrew D Hershey, Samantha Irwin, Liron Rabany, et al.
Journal of Child Neurology|September 8, 2025
An Occurrence of Mass Psychogenic Illness: LeRoy, New YorkJennifer McVige, Lanie Masset, Laszlo Mechtler, et al.
Journal of Managed Care & Specialty Pharmacy|September 30, 2023
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodiesTodd J Schwedt, Jae Lee, Kerry Knievel, et al.
Headache|July 29, 2024
American Headache Society white paper on treatment of post-traumatic headache from concussion in youthCarlyn Patterson Gentile, Scott Rosenthal, Heidi Blume, et al.
Cephalalgia : an International Journal of Headache|August 28, 2023
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trialRichard B Lipton, Rashmi B Halker Singh, Laszlo Mechtler, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Continuum (Minneapolis, Minn.)|June 4, 2015
Coding in behavioral neurology and neuropsychiatryJoseph V Fritz, Jennifer McVige, Laszlo Mechtler
Current Pain and Headache Reports|June 27, 2016
Basilar Invagination, Basilar Impression, and Platybasia: Clinical and Imaging AspectsNandor K Pinter, Jennifer McVige, Laszlo Mechtler
Headache|October 26, 2022
A multicenter, randomized, double-blind, placebo-controlled, crossover trial to evaluate the efficacy and safety of zolmitriptan nasal spray for the acute treatment of migraine in patients aged 6 to 11 years, with an open-label extensionMarcy E Yonker, Jennifer McVige, Leonid Zeitlin, et al.
Sports Health|March 30, 2016
A Practical Concussion Physical Examination ToolboxJason M Matuszak, Jennifer McVige, Jacob McPherson, et al.
Frontiers in Neurology|January 24, 2022
Real-World Evidence for the Safety and Efficacy of CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment for Migraine Prevention in Adult Patients With Chronic MigraineLaszlo Mechtler, Nicolas Saikali, Jennifer McVige, et al.
Pain Medicine (Malden, Mass.)|June 29, 2021
Comparison of Remote Electrical Neuromodulation and Standard-Care Medications for Acute Treatment of Migraine in Adolescents: A Post Hoc AnalysisAndrew D Hershey, Samantha Irwin, Liron Rabany, et al.
Journal of Child Neurology|September 8, 2025
An Occurrence of Mass Psychogenic Illness: LeRoy, New YorkJennifer McVige, Lanie Masset, Laszlo Mechtler, et al.
Journal of Managed Care & Specialty Pharmacy|September 30, 2023
Real-world persistence and costs among patients with chronic migraine treated with onabotulinumtoxinA or calcitonin gene-related peptide monoclonal antibodiesTodd J Schwedt, Jae Lee, Kerry Knievel, et al.
Headache|July 29, 2024
American Headache Society white paper on treatment of post-traumatic headache from concussion in youthCarlyn Patterson Gentile, Scott Rosenthal, Heidi Blume, et al.
Cephalalgia : an International Journal of Headache|August 28, 2023
Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trialRichard B Lipton, Rashmi B Halker Singh, Laszlo Mechtler, et al.
Pageof 2